Results 241 to 250 of about 2,285,924 (374)

A Case with Membranous Glomerulonephritis and Myelodysplastic Syndrome

, 1992
S. Paydaş, Semra Paydaş, I Tuncer, Suzan Zorludemir, Gülfiliz Gönlüşen   +4 more
openalex   +1 more source

Altered surface expression of effector cell molecules on neutrophils in myelodysplastic syndromes [PDF]

, 1997
Akimichi Ohsaka, Katsu Saionji, J Igari, Norimichi Watanabe, Kazuhisa Iwabuchi, Isao Nagaoka   +5 more
openalex   +1 more source

Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia [PDF]

, 2015
Liberante, Fabio Giuseppe, McMullin, Mary-Frances, Mills, Kenneth Ian, Pouryahya, Tara, Zhang, Shu-Dong   +4 more
core   +1 more source

Targeting CD70 in cancer: Mechanisms of immune escape and translational opportunities

Clinical and Translational Discovery, Volume 5, Issue 6, December 2025.
Hypoxia, oncogenic signaling (e.g., MAPK, STAT3), and histone modifications promote CD70 overexpression in cancer cells. Viral infections like EBV and HTLV‐1 induce CD70 expression in tumor and transformed immune cells. Tyrosine kinase inhibitors and chemotherapeutic agents induce CD70 expression through therapy‐related stress in cancer cells ...
Akash Sabarwal, Saba Tabasum, Laxminarayan Rawat, Soumitro Pal   +3 more
wiley   +1 more source

Distinct routes of clonal progression in SF3B1-mutant myelodysplastic syndromes. [PDF]

Blood Adv
Sarchi M, Clough CA, Gallì A, Picone C, Ferrari B, Crosse EI, Baquero Galvis LD, Fiducioso C, Aydinyan N, Creamer JP, Pozzi S, Molteni E, Elena C, Bradley RK, Malcovati L, Doulatov S.   +15 more
europepmc   +1 more source

How I treat myelodysplastic syndromes of childhood.

Blood, 2018
F. Locatelli, B. Strahm
semanticscholar   +1 more source

Secondary Malignancies Following CAR T‐Cell Therapy for B‐Cell Malignancies: A Retrospective Analysis

eJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction Chimeric antigen receptor T‐cell (CART) therapy has shown clinical efficacy in relapsed and refractory large B‐cell malignancies. There is emerging data on the long‐term complications including risk of secondary malignancies. We aimed to describe the incidence and characteristics of secondary malignancies following CART therapy ...
Joanne Britto, Audrey Y. H. Dong, Gregory Pond, Tobias Berg, Kylie Lepic, Tom Kouroukis, Gwynivere A. Davies, Graeme Fraser, Ronan Foley, Amaris K. Balitsky   +9 more
wiley   +1 more source

Red blood cell transfusion practice and cardiac comorbidities in patients with myelodysplastic syndromes. [PDF]

Transfusion
Mo A, Wood EM, Shortt J, McQuilten ZK.
europepmc   +1 more source

Three-Lineage Hemopoietic Precursor Cells and Effectiveness of Recombinant Human Erythropoietin in Patients with Myelodysplastic Syndromes.

, 1992
Y Fukushima, YOHKO KANNO, Akira Miura
openalex   +2 more sources

Cytogenetic abnormalities and therapy-related myelodysplastic syndromes in rheumatic disease [PDF]

, 1998
Conor McCarthy, Susan Sheldon, Charles W. Ross, W. Joseph McCune   +3 more
openalex   +1 more source